Oncology Corporate Profile
Genprex Inc. is a biopharmaceutical company founded to bridge critical gaps in the cancer therapeutics sector by developing products to unlock the potential of proven but limited cancer drugs. The Company is working to expand clinical populations benefitting from targeted, small molecule therapies by using its biologic agents to combine small molecule drugs to promote genome-wide applications of the combination therapy and to participate in expanding proven markets. The Company's biologics are designed to program cells to overcome intrinsic and acquired small molecule drug resistance without additional toxicities and to sensitize cancer cells to small and large molecule cancer drugs.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|oncoprex (+ erlotinib)||pan-kinase inhibitor||Non Small Cell Lung Cancer (NSCLC)||II|
|oncoprex||pan-kinase inhibitor||Non Small Cell Lung Cancer (NSCLC)||I|
|oncoprex||pan-kinase inhibitor||Various cancer types||Preclinical|
View additional information on product candidates here »